In order to improve EV specificity, many cytofluorimetric studies analyzed the expression of CD138, the gold standard marker to detect MM cells, showing that plasma CD138+EVs are higher in MM patients compared to healthy donors, and that their levels are associated with disease phase and therapeutic response [45, 47]. Here, SDC1 is linked to Miyoshi myopathy.